<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Burnier P</dc:creator>
  <dc:creator>Tappy L</dc:creator>
  <dc:creator>Jéquier E</dc:creator>
  <dc:creator>Schneeberger D</dc:creator>
  <dc:creator>Chioléro R</dc:creator>
  <dc:date>1992</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The metabolic and respiratory effects of intravenous 0.5 M sodium acetate (at a rate of 2.5 mmol/min during 120 min) were studied in nine normal human subjects. O2 consumption (VO2) and CO2 production (VCO2) were measured continuously by open-circuit indirect calorimetry. VO2 increased from 251 +/- 9 to 281 +/- 9 ml/min (P &lt; 0.001), energy expenditure increased from 4.95 +/- 0.17 kJ/min baseline to 5.58 +/- 0.16 kJ/min (P &lt; 0.001), and VCO2 decreased nonsignificantly (211 +/- 7 ml/min vs. 202 +/- 7 ml/min, NS). The extrapulmonary CO2 loss (i.e., bicarbonate generation and excretion) was estimated at 48 +/- 5 ml/min. This observation is consistent with 1 mol of bicarbonate generated from 1 mol of acetate metabolized. Alveolar ventilation decreased from 3.5 +/- 0.2 l/min basal to 3.1 +/- 0.2 l/min (P &lt; 0.001). The minute ventilation (VE) to VO2 ratio decreased from 22.9 +/- 1.3 to 17.6 +/- 0.9 l/l (P &lt; 0.005), arterial PO2 decreased from 93.2 +/- 1.9 to 78.7 +/- 1.6 mmHg (P &lt; 0.0001), arterial PCO2 increased from 39.2 +/- 0.7 to 42.1 +/- 1.1 mmHg (P &lt; 0.0001), pH from 7.40 +/- 0.005 to 7.50 +/- 0.007 (P &lt; 0.005), and arterial bicarbonate concentration from 24.2 +/- 0.7 to 32.9 +/- 1.1 (P &lt; 0.0001). These observations indicate that sodium acetate infusion results in substantial extrapulmonary CO2 loss, which leads to a relative decrease of total and alveolar ventilation.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/93618</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpregu.1992.263.6.R1271</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/1481938</dc:relation>
  <dc:source>The American journal of physiology. - 1992</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Acetates</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Acetic Acid</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Bicarbonates</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Fatty Acids, Nonesterified</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Hemodynamics</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Infusions, Intravenous</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Metabolism</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Oxidation-Reduction</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Pulmonary Gas Exchange</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Reference Values</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Respiration</dc:subject>
  <dc:title xmlns:ns16="xml" ns16:lang="en">Metabolic and respiratory effects of infused sodium acetate in healthy human subjects.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
